To me, diseases like muscular dystrophy are why the expedited approval pathways are so important.
Thank you very much, Mr. Chairman.
Of course, Chairman Waxman, or Ranking Member Waxman, deserves a lot of credit for starting the user fee agreements, whi...
I applaud the current Administration's increased emphasis on EHS.
If we are going to maintain competitiveness, then the United States needs to make strong and sustained investment in nan...
Without a strong EHS research program on nanotechnology, we will be left with uncertainties surrounding potential risks ...
As a former nurse, I recognize the need to understand and mitigate the potential risks to new technologies, including na...
As a long-time member of the Committee, I am proud that the Committee recognized a need for an increased level of invest...
the MD Care Act, Mr. Chairman, that is a good Bill and one that I hope we can have a legislative hearing and a markup on...
I am particularly interested in the development and approval of drugs for rare diseases.
We need a strong nano-EHS research program to protect the public and to ensure that any nanotechnology regulations will ...
Thank you for having this hearing, and especially thanks to the chairman and ranking member of the full committee for pu...
Not only is it not being considered, but I will just tell you, not a month goes by that someone is not in my office with...
Authorizing the enlistment of Dreamers will result in improved recruitment results and attendant gains in unit manning a...
The legislation would remove some aspects of federal oversight under the FPA that potentially could cripple the many ben...
Senators David Vitter (R-LA) and John Cornyn (R-TX) are also original sponsors of this legislation.
The President said, when he sold the idea of the Affordable Care Act, that if you like what you have you can keep it, yo...
In many, many, many--too many--instances, that has proven not to be true, which has been very damaging not only to the P...
